| 12156870 |
Antibody drug conjugates comprising sting agonists |
Jeremy R. DUVALL, Keith W. BENTLEY, Raghida BUKHALID, Naniye CETINBAS, Marc I. DAMELIN +5 more |
2024-12-03 |
| 9938281 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta |
Abdelghani Achab, Michael D. Altman, Yongqi Deng, Solomon D. Kattar, Jason Katz +16 more |
2018-04-10 |
| 9682978 |
2,6,7 substituted purines as HDM2 inhibitors |
Matthew Christopher, Francesc Xavier Fradera Llinas, Michelle R. Machacek, Michelle Martinez, Michael H. Reutershan +5 more |
2017-06-20 |
| 9637493 |
Substituted pyrrolopyrimidines as HDM2 inhibitors |
Christopher J. Dinsmore, Francesc Xavier Fradera Llinas, Amit Ashokro Kudale, Michelle R. Machacek, Michael H. Reutershan +6 more |
2017-05-02 |
| 9540377 |
2,6,7,8 substituted purines as HDM2 inhibitors |
Carolyn Michele Cammarano, Matthew Christopher, Christopher J. Dinsmore, Ronald J. Doll, Francesc Xavier Fradera Llinas +16 more |
2017-01-10 |
| 9227971 |
Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors |
M. Arshad Siddiqui, Yang Nan, Mehul Patel, Panduranga Adulla P. Reddy, Umar Faruk Mansoor +12 more |
2016-01-05 |
| 8796460 |
Compounds for inhibiting KSP kinesin activity |
M. Arshad Siddiqui, Chaoyang Dai, Umar Faruk Mansoor, Lalalnthi Dilrukshi Vitharana, Angie R. Angeles |
2014-08-05 |
| 8569336 |
Compounds for the treatment of inflammatory disorders |
Ling Tong, Brian J. Lavey, Bandarpalle B. Shankar, Seong Heon Kim, Wensheng Yu +16 more |
2013-10-29 |
| 8541572 |
Compounds for the treatment of inflammatory disorders |
Joseph A. Kozlowski, Wensheng Yu, Michael K. C. Wong, Seong Heon Kim, Ling Tong +15 more |
2013-09-24 |
